This presentation offers an educational overview of autoimmune central nervous system (CNS) disorders, evaluations (including antibody testing), and treatments.
Mayo Clinic has launched a first-of-its-kind clinical test that will be used to help patients who may be at a diagnostic “dead end” with other genetic testing. The mate-pair sequencing test can identify chromosome alterations or “breakpoints” involved in chromosome rearrangements, pinpointing the precise genes involved.
Clinical Laboratory News recently highlighted a Mayo Clinic study that shows how plasma ceramides may predict cardiovascular events in patients with or without coronary artery disease.
European Heart Journal recently highlighted Mayo Clinic’s new blood test that may predict cardiovascular events in patients with or without coronary artery disease.